Chemical Biology
Our Services
-
•Synthesis of core intermediate on 1-3 g scale (ease of synthesis)
•Library small molecule chemistry carried out on 10-50 mg scale
•Initial small molecule library will contain ‘hit’ and diverse analogues to explore SAR
-
•Post reaction work-up carried out using solid phase reagents
•All compounds have LC-MS checks to determine reaction success and purification requirements
•All compounds requiring purification are carried out via preparative HPLC/SFC
-
•In house electronic notebook and compound registration systems in place
•Individual projects ring-fenced and firewalled to protect information
•All final compounds accurately weighed, barcoded and tracked
-
Description text goes hereAll compounds screened in desired biological assays (biochemical and/or cell based)
•Data generated used to inform next iteration of compound library generation
•Off-target screening
•In addition, rounds of more focussed libraries, such as solubility, stability, cLogP (partner)
Capabilities
Located in the Patrick G Johnston Centre for Cancer Research (PGJCCR), gain access to our chemical biology team that has extensive research in developing potent and selective compounds.
•Technology Enabled Synthesis or TES is a medicinal chemistry platform that allows for rapid SAR (Structure Activity Relationship) during the ‘Hit validation’ and early ‘Hit to lead’ programmes
•Using cutting edge technologies, we can carry out early-stage drug development work in a pre-competitive environment
Team
Dr Rich Williams
Academic Lead
Small molecule inhibitor development/ protease biology
Robert Haydon
Research Technician
Process scale-up, chemical analysis
Dr. Emma Clyde Allen
Research Fellow
Small molecule inhibitor development/ protease biology
Dr Benjamin Owen
Research Fellow
Drug development
Our technology
Visit us
The Patrick G. Johnston Centre for Cancer Research 97 Lisburn Rd, Belfast BT9 7AE
Hours
Monday–Friday
8am–5pm
Email rich.wiliams@qub.ac.uk